- Home
- WAL vs ROIV Comparison
WAL vs ROIV Comparison
Compare WAL & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAL
- ROIV
- Stock Information
- Founded
- WAL 1994
- ROIV 2014
- Country
- WAL United States
- ROIV United Kingdom
- Employees
- WAL N/A
- ROIV N/A
- Industry
- WAL Major Banks
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- WAL Finance
- ROIV Health Care
- Exchange
- WAL Nasdaq
- ROIV Nasdaq
- Market Cap
- WAL 7.8B
- ROIV 8.4B
- IPO Year
- WAL 2005
- ROIV N/A
- Fundamental
- Price
- WAL $71.45
- ROIV $10.87
- Analyst Decision
- WAL Strong Buy
- ROIV Buy
- Analyst Count
- WAL 15
- ROIV 4
- Target Price
- WAL $96.33
- ROIV $17.50
- AVG Volume (30 Days)
- WAL 848.7K
- ROIV 5.2M
- Earning Date
- WAL 07-17-2025
- ROIV 05-29-2025
- Dividend Yield
- WAL 2.13%
- ROIV N/A
- EPS Growth
- WAL 6.13
- ROIV N/A
- EPS
- WAL 7.28
- ROIV N/A
- Revenue
- WAL $3,049,400,000.00
- ROIV $122,585,000.00
- Revenue This Year
- WAL $13.26
- ROIV N/A
- Revenue Next Year
- WAL $9.87
- ROIV N/A
- P/E Ratio
- WAL $9.82
- ROIV N/A
- Revenue Growth
- WAL 11.37
- ROIV 140.04
- 52 Week Low
- WAL $56.70
- ROIV $8.73
- 52 Week High
- WAL $98.10
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- WAL 44.56
- ROIV 51.00
- Support Level
- WAL $70.45
- ROIV $10.58
- Resistance Level
- WAL $80.47
- ROIV $11.07
- Average True Range (ATR)
- WAL 1.95
- ROIV 0.30
- MACD
- WAL -0.48
- ROIV -0.04
- Stochastic Oscillator
- WAL 11.50
- ROIV 30.21
About WAL Western Alliance Bancorporation (DE)
Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.